AUTL - Company ID 0001730463
The table below shows Autolus Therapeutics plc's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $104.13M | $227.38M | $239.57M | $382.44M | - | - |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $24.02M | $15.00K | $109.00K | $121.00K | - | - |
| Inventory | $33.21M | $4.14M | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $435.92M |
| $660.93M |
| $275.30M |
| $425.77M |
| $346.95M |
| $196.98M |
| Property, plant & equipment | $63.56M | $49.55M | $34.86M | $35.21M | $33.54M | $38.05M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $589.07M | $782.73M | $375.38M | $490.27M | $405.56M | $294.24M |
| Accounts payable | $3.08M | $1.97M | $103.00K | $531.00K | $431.00K | $2.26M |
| Total current liabilities | $73.44M | $60.74M | $44.74M | $46.37M | $28.55M | $33.63M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $410.94M | $355.40M | $263.91M | $191.60M | $92.24M | $84.20M |
| Retained earnings | -$1.39B | -$1.10B | -$878.56M | -$670.18M | -$521.34M | -$379.24M |
| Total equity | $178.13M | $427.32M | $111.47M | $298.67M | $313.32M | $210.03M |